Report Detail
Global Gene Editing Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4564298 |
- 07 November, 2023 |
- Global |
- 110 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Gene Editing Drug market size was valued at USD 1295.4 million in 2022 and is forecast to a readjusted size of USD 3274.3 million by 2029 with a CAGR of 14.2% during review period.
Gene editing drugs are an innovative biomedical treatment method that treat diseases by directly modifying a patient's genes. These drugs use various gene editing technologies, such as CRISPR-Cas9, ZFN (zinc finger nuclease), to precisely edit the patient's DNA sequence. Overall, the field of gene-editing drugs has great potential to treat a variety of diseases, but the field will continue to evolve and advance as ethical, safety, and legal issues are addressed.
The Global Info Research report includes an overview of the development of the Gene Editing Drug industry chain, the market status of General Hospital (CRISPR-Cas9 Gene Editing Drugs, Zinc Finger Nuclease Gene Editing Drugs), Specialty Hospital (CRISPR-Cas9 Gene Editing Drugs, Zinc Finger Nuclease Gene Editing Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Editing Drug.
Regionally, the report analyzes the Gene Editing Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Editing Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gene Editing Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Editing Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., CRISPR-Cas9 Gene Editing Drugs, Zinc Finger Nuclease Gene Editing Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Editing Drug market.
Regional Analysis: The report involves examining the Gene Editing Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Editing Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gene Editing Drug:
Company Analysis: Report covers individual Gene Editing Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Editing Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (General Hospital, Specialty Hospital).
Technology Analysis: Report covers specific technologies relevant to Gene Editing Drug. It assesses the current state, advancements, and potential future developments in Gene Editing Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Editing Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gene Editing Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
CRISPR-Cas9 Gene Editing Drugs
Zinc Finger Nuclease Gene Editing Drugs
Others
Market segment by Application
General Hospital
Specialty Hospital
Major players covered
CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
Sangamo Therapeutics
Bluebird Bio
Beam Therapeutics
Yaotang Biotechnology
ICamuno Biotherapeutics
Reforgene Medicine
Star Eyed Creature
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gene Editing Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gene Editing Drug, with price, sales, revenue and global market share of Gene Editing Drug from 2018 to 2023.
Chapter 3, the Gene Editing Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gene Editing Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Gene Editing Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gene Editing Drug.
Chapter 14 and 15, to describe Gene Editing Drug sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Gene Editing Drug
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Gene Editing Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 CRISPR-Cas9 Gene Editing Drugs
- 1.3.3 Zinc Finger Nuclease Gene Editing Drugs
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Gene Editing Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 General Hospital
- 1.4.3 Specialty Hospital
- 1.5 Global Gene Editing Drug Market Size & Forecast
- 1.5.1 Global Gene Editing Drug Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Gene Editing Drug Sales Quantity (2018-2029)
- 1.5.3 Global Gene Editing Drug Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 CRISPR Therapeutics
- 2.1.1 CRISPR Therapeutics Details
- 2.1.2 CRISPR Therapeutics Major Business
- 2.1.3 CRISPR Therapeutics Gene Editing Drug Product and Services
- 2.1.4 CRISPR Therapeutics Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 CRISPR Therapeutics Recent Developments/Updates
- 2.2 Editas Medicine
- 2.2.1 Editas Medicine Details
- 2.2.2 Editas Medicine Major Business
- 2.2.3 Editas Medicine Gene Editing Drug Product and Services
- 2.2.4 Editas Medicine Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Editas Medicine Recent Developments/Updates
- 2.3 Intellia Therapeutics
- 2.3.1 Intellia Therapeutics Details
- 2.3.2 Intellia Therapeutics Major Business
- 2.3.3 Intellia Therapeutics Gene Editing Drug Product and Services
- 2.3.4 Intellia Therapeutics Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Intellia Therapeutics Recent Developments/Updates
- 2.4 Sangamo Therapeutics
- 2.4.1 Sangamo Therapeutics Details
- 2.4.2 Sangamo Therapeutics Major Business
- 2.4.3 Sangamo Therapeutics Gene Editing Drug Product and Services
- 2.4.4 Sangamo Therapeutics Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Sangamo Therapeutics Recent Developments/Updates
- 2.5 Bluebird Bio
- 2.5.1 Bluebird Bio Details
- 2.5.2 Bluebird Bio Major Business
- 2.5.3 Bluebird Bio Gene Editing Drug Product and Services
- 2.5.4 Bluebird Bio Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Bluebird Bio Recent Developments/Updates
- 2.6 Beam Therapeutics
- 2.6.1 Beam Therapeutics Details
- 2.6.2 Beam Therapeutics Major Business
- 2.6.3 Beam Therapeutics Gene Editing Drug Product and Services
- 2.6.4 Beam Therapeutics Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Beam Therapeutics Recent Developments/Updates
- 2.7 Yaotang Biotechnology
- 2.7.1 Yaotang Biotechnology Details
- 2.7.2 Yaotang Biotechnology Major Business
- 2.7.3 Yaotang Biotechnology Gene Editing Drug Product and Services
- 2.7.4 Yaotang Biotechnology Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Yaotang Biotechnology Recent Developments/Updates
- 2.8 ICamuno Biotherapeutics
- 2.8.1 ICamuno Biotherapeutics Details
- 2.8.2 ICamuno Biotherapeutics Major Business
- 2.8.3 ICamuno Biotherapeutics Gene Editing Drug Product and Services
- 2.8.4 ICamuno Biotherapeutics Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 ICamuno Biotherapeutics Recent Developments/Updates
- 2.9 Reforgene Medicine
- 2.9.1 Reforgene Medicine Details
- 2.9.2 Reforgene Medicine Major Business
- 2.9.3 Reforgene Medicine Gene Editing Drug Product and Services
- 2.9.4 Reforgene Medicine Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Reforgene Medicine Recent Developments/Updates
- 2.10 Star Eyed Creature
- 2.10.1 Star Eyed Creature Details
- 2.10.2 Star Eyed Creature Major Business
- 2.10.3 Star Eyed Creature Gene Editing Drug Product and Services
- 2.10.4 Star Eyed Creature Gene Editing Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Star Eyed Creature Recent Developments/Updates
3 Competitive Environment: Gene Editing Drug by Manufacturer
- 3.1 Global Gene Editing Drug Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Gene Editing Drug Revenue by Manufacturer (2018-2023)
- 3.3 Global Gene Editing Drug Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Gene Editing Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Gene Editing Drug Manufacturer Market Share in 2022
- 3.4.2 Top 6 Gene Editing Drug Manufacturer Market Share in 2022
- 3.5 Gene Editing Drug Market: Overall Company Footprint Analysis
- 3.5.1 Gene Editing Drug Market: Region Footprint
- 3.5.2 Gene Editing Drug Market: Company Product Type Footprint
- 3.5.3 Gene Editing Drug Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Gene Editing Drug Market Size by Region
- 4.1.1 Global Gene Editing Drug Sales Quantity by Region (2018-2029)
- 4.1.2 Global Gene Editing Drug Consumption Value by Region (2018-2029)
- 4.1.3 Global Gene Editing Drug Average Price by Region (2018-2029)
- 4.2 North America Gene Editing Drug Consumption Value (2018-2029)
- 4.3 Europe Gene Editing Drug Consumption Value (2018-2029)
- 4.4 Asia-Pacific Gene Editing Drug Consumption Value (2018-2029)
- 4.5 South America Gene Editing Drug Consumption Value (2018-2029)
- 4.6 Middle East and Africa Gene Editing Drug Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Gene Editing Drug Sales Quantity by Type (2018-2029)
- 5.2 Global Gene Editing Drug Consumption Value by Type (2018-2029)
- 5.3 Global Gene Editing Drug Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Gene Editing Drug Sales Quantity by Application (2018-2029)
- 6.2 Global Gene Editing Drug Consumption Value by Application (2018-2029)
- 6.3 Global Gene Editing Drug Average Price by Application (2018-2029)
7 North America
- 7.1 North America Gene Editing Drug Sales Quantity by Type (2018-2029)
- 7.2 North America Gene Editing Drug Sales Quantity by Application (2018-2029)
- 7.3 North America Gene Editing Drug Market Size by Country
- 7.3.1 North America Gene Editing Drug Sales Quantity by Country (2018-2029)
- 7.3.2 North America Gene Editing Drug Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Gene Editing Drug Sales Quantity by Type (2018-2029)
- 8.2 Europe Gene Editing Drug Sales Quantity by Application (2018-2029)
- 8.3 Europe Gene Editing Drug Market Size by Country
- 8.3.1 Europe Gene Editing Drug Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Gene Editing Drug Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Editing Drug Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Gene Editing Drug Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Gene Editing Drug Market Size by Region
- 9.3.1 Asia-Pacific Gene Editing Drug Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Gene Editing Drug Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Gene Editing Drug Sales Quantity by Type (2018-2029)
- 10.2 South America Gene Editing Drug Sales Quantity by Application (2018-2029)
- 10.3 South America Gene Editing Drug Market Size by Country
- 10.3.1 South America Gene Editing Drug Sales Quantity by Country (2018-2029)
- 10.3.2 South America Gene Editing Drug Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Editing Drug Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Gene Editing Drug Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Gene Editing Drug Market Size by Country
- 11.3.1 Middle East & Africa Gene Editing Drug Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Gene Editing Drug Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Gene Editing Drug Market Drivers
- 12.2 Gene Editing Drug Market Restraints
- 12.3 Gene Editing Drug Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Gene Editing Drug and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Gene Editing Drug
- 13.3 Gene Editing Drug Production Process
- 13.4 Gene Editing Drug Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Gene Editing Drug Typical Distributors
- 14.3 Gene Editing Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Gene Editing Drug. Industry analysis & Market Report on Gene Editing Drug is a syndicated market report, published as Global Gene Editing Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Gene Editing Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
